文献速递外周动脉疾病

脊髓电刺激治疗严重肢体缺血患者一年临床结局

The Clinical Outcomes in Patients with Critical Limb Ischemia One Year after Spinal Cord Stimulation.
PubMed 文献 · Ann Vasc Surg · 2019-02-22

这项前瞻性队列研究纳入56例严重肢体缺血患者,评估脊髓电刺激一年后的临床结局。结果显示74%患者临床结局积极,9.3%无变化,16.7%不良;基线TcPO2低且直立试验无增益与不良结局相关,年龄校正Charlson合并症指数>5和缺血症状持续时间也有负面影响。

要点

  • 脊髓电刺激一年后74%的严重肢体缺血患者临床结局积极。
  • 基线TcPO2<10 mmHg且直立试验无增益提示不良结局。
  • 高合并症负担和长缺血症状持续时间是负面因素。

核心结论

  • 多数严重肢体缺血患者脊髓电刺激一年后临床结局积极。

研究设计与样本

  • 前瞻性队列研究,纳入56例严重肢体缺血患者。
  • 所有患者脊髓电刺激前后用Rutherford量表和患足经皮氧分压(TcPO2,mmHg)评估临床变化,并采用主动直立试验评估外周灌注功能状态。

主要发现

  • 脊髓电刺激一年后,74%患者临床结局积极,9.3%无变化,16.7%不良。
  • 脊髓电刺激前TcPO2显著降低,为10.5(6.4-16.0)mmHg,外周微血管功能状态也受损。
  • 治疗一年后,超过70%患者TcPO2显著升高且微血管适应机制改善。
  • 逻辑回归分析显示,初始TcPO2低(<10 mmHg)且直立试验中TcPO2无增益与脊髓电刺激后不良临床结局相关。
  • 直立试验中TcPO2增益至>10 mmHg与脊髓电刺激后积极临床结局相关。

关键数值与推荐

  • 年龄校正Charlson合并症指数>5和严重缺血症状持续时间对脊髓电刺激后临床结局有负面影响。
  • 基线TcPO2<10 mmHg的患者若仍存足够微循环储备能力,仍可恢复。

临床怎么用

  • 脊髓电刺激可用于严重肢体缺血患者,但需评估基线TcPO2及直立试验微循环储备。
  • 高合并症负担和长缺血症状持续时间提示预后较差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to evaluate the long-term outcomes of spinal cord stimulation in patients with critical limb ischemia and to test the hypothesis that the dynamics of clinical changes one year after therapy depend both on the clinical determinants associated with the underlying disease and on factors related to systemic atherosclerosis. METHODS: This prospective cohort study included 56 patients with critical limb ischemia. All patients before and after spinal cord stimulation were examined in terms of the dynamics of their clinical changes using the Rutherford scale and transcutaneous oxygen tension (TcPO2, mm Hg) in the affected foot. The active orthostatic test was used to assess the functional state of peripheral perfusion. RESULTS: One year after spinal cord stimulation, 74% of patients showed positive clinical outcomes. No changes were observed in 9.3% of patients, whereas adverse clinical outcomes were revealed in 16.7% of cases. The TcPO2 values were significantly reduced before spinal cord stimulation: 10.5 (6.4-16.0) mm Hg. The functional status of the peripheral microvasculature was also disturbed. One year after therapy, TcPO2 significantly increased and the adaptive mechanisms of the microvasculature were improved in more than 70% of patients. Logistic regression analysis showed that the initially low TcPO2 values (<10 mm Hg) with a lack of gain in TcPO2 during the orthostatic test are associated with the negative clinical outcomes after spinal cord stimulation. The gain in TcPO2 during the orthostatic test to >10 mm Hg is associated with the positive clinical outcomes after spinal cord stimulation. The age-adjusted Charlson Comorbidity Index >5 and duration of critical ischemic symptoms also had a negative effect on the clinical outcomes after spinal cord stimulation. CONCLUSIONS: The positive clinical outcomes were revealed in most patients with critical limb ischemia one year after spinal cord stimulation. The low values of peripheral tissue metabolism with the disturbed functional status of the microvasculature are associated with the negative clinical outcome. The patients with baseline TcPO2 <10 mm Hg can recover if they still have a sufficient microcirculatory reserve capacity. Duration of critical ischemic symptoms and high comorbidity burden with allowance for age are negative factors affecting the clinical outcome.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Klinkova A, Kamenskaya O, Ashurkov A, et al. The Clinical Outcomes in Patients with Critical Limb Ischemia One Year after Spinal Cord Stimulation. Ann Vasc Surg. 2019. PMID: 30802587. doi:10.1016/j.avsg.2018.12.093

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。